Now accepting new Members for precision longevity programs.Learn more
The Science
Longevity is not a supplement stack. It is the disciplined, decades-early management of the four systems that decide how long you stay healthy.
The premise
For most people the last decade of life is spent managing decline — medications, hospitals, shrinking independence. That gap between total years and healthy years is the real enemy, and it is measurable.
Longevity medicine exists to compress that decline into the smallest possible window: to keep the curve of your capability high and flat for as long as biology allows, then let it fall late and fast — instead of early and slowly.
Everything Genoryx does — 400+ markers, quarterly retesting, physician-built protocols — serves that single graph.
Almost everything that shortens a healthy life runs through four biological systems. Each one begins its decline silently, decades before symptoms — which is exactly why we measure them early and repeatedly.
The largest cause of death in India — and it starts 20-30 years before the event.
Atherosclerosis is a decades-long process. The markers that predict it — ApoB and Lp(a) — are rarely on a standard panel, yet they are measurable in your thirties, when there is still time to change the trajectory.
What we watch
ApoB, Lp(a), hs-CRP, HbA1c, fasting insulin, blood pressure, VO2 max
Most cancers are diagnosed late because nothing was looking early.
Survival is a function of stage at detection. A structured, physician-led screening calendar — not a one-off scan — is what shifts the odds.
What we watch
Age- and risk-guided screening calendar, inflammatory markers, family-history mapping
Cognitive decline begins silently in midlife; by symptoms, decades have passed.
The brain ages through its blood vessels and its metabolism. The same markers that protect your heart protect your cognition — measured early, they are actionable.
What we watch
Metabolic and vascular risk markers, sleep quality, homocysteine, B12 / D status
Falls and frailty end independence — muscle and bone decide how long you stay strong.
Muscle is the organ of longevity. Sarcopenia starts in the forties and accelerates — but it responds to training and protocols better than almost any other system.
What we watch
DEXA bone density and lean mass, grip strength, VO2 max, vitamin D, hormone panel
Aging does not announce itself. Decade by decade, this is what is happening under “feeling fine” — and what each decade rewards.
What begins
Arterial plaque begins in susceptible lipid profiles. Insulin sensitivity starts drifting. Peak bone mass is behind you.
The move
The cheapest decade to act — baseline everything, correct early.
What begins
Muscle mass declines ~3-8% per decade from here. Hormones shift. Blood pressure creeps. First metabolic red flags surface.
The move
Trajectory-setting decade — training, metabolic and hormonal correction compound from here.
What begins
Cardiovascular events begin appearing in South Asian men. Bone density loss accelerates in women post-menopause.
The move
Screening intensity rises; prevention still outperforms treatment.
What begins
The gap between biological ages widens dramatically — two 65-year-olds can be a decade apart functionally.
The move
Everything invested earlier pays out here — strength, cognition, independence.
A number without interpretation is trivia. Interpreted by a physician, re-measured every quarter, it becomes the most powerful instrument in medicine: a trend.
A sample of what 400+ markers actually buys you: not more numbers — fewer blind spots. Every marker below is measured, trended, and interpreted by a physician.
Counts the particles that actually cause plaque — better than LDL-C alone.
Genetic risk factor most Indians have never had measured. Once in a lifetime can change everything.
Vascular inflammation — the fire that accelerates plaque.
Elevated levels track with vascular and cognitive risk; often responds to B-vitamin status.
A fast, telling window into metabolic health.
Three-month average blood sugar — the slow drift toward diabetes, visible early.
Insulin resistance shows here years before glucose ever rises.
Metabolic stress and dietary load marker; tracks with hypertension risk.
Fatty liver is the silent epidemic of Indian metros — visible in two numbers.
Kidney reserve — the organ you never think about until it is late.
Energy, muscle, mood, drive — declining silently in urban Indian men.
The axis that governs female metabolic and bone health through perimenopause.
The metabolic thermostat — subclinical dysfunction is common and missable.
Chronic stress made measurable.
Recovery and anabolic reserve — context for everything above.
How old your body functionally is — the headline number, and it moves.
"Inflammaging" — the slow burn that accelerates every system.
Iron status and an inflammation signal in one.
Membrane-level nutrition your diet claims but rarely delivers.
Chronically low across India — cheap to fix, expensive to ignore.
The single strongest fitness predictor of long-term mortality risk in the literature.
Gold-standard measurement of the muscle and bone you will live in at 80.
A deceptively simple marker that tracks whole-body resilience.
Autonomic recovery — how well your system absorbs stress.
What your meals actually do to you, hour by hour, not on average.
This is a sample. Your full panel spans 400+ markers across 12 organ systems — every one reviewed with you, in person, by a physician.
Explore the diagnostics
Gold-standard X-ray measurement of bone density, lean mass, and visceral fat — the fat that matters.
Cardiopulmonary exercise test measuring your aerobic engine — among the strongest known predictors of healthy lifespan.
DNA methylation clocks estimate biological age and pace of aging — the number our protocols are built to move.
Two to four weeks of real-world metabolic data — your actual responses to your actual life.
Standard lab ranges describe a population — including its unwell members. You can sit “within normal limits” on every line of a report while your risk quietly compounds for twenty years.
Genoryx panels are read against longevity-optimized ranges: the zones where long-term outcome data is strongest. Then we re-measure quarterly, because a single snapshot is a guess — a trend is knowledge.
Most reference data — and most wellness advice — is built on Western cohorts. That mismatch is not a detail. It is the difference between “you're fine” and “we should act now.”
earlier onset of cardiovascular disease in South Asian populations
thresholds at which insulin resistance and metabolic risk appear
lipid patterns — higher triglycerides, lower HDL at the same weight
Our physicians read every marker in the context of the population you actually belong to — one of the reasons physician review matters more than a printed report.
Not every intervention deserves the same confidence — and a clinic that pretends otherwise is selling, not treating. This is how we hold ourselves honest.
Strength training, VO2 max development, sleep architecture, blood-pressure and lipid management, glycemic control
The core of every Genoryx protocol. Unglamorous, decisive, non-negotiable.
Hormone optimization when clinically indicated, targeted supplementation against measured deficiency, structured recovery (compression, heat/cold)
Deployed when your markers say so — never as a default, always re-measured.
NAD+ restoration, photobiomodulation (red light), HBOT for non-approved indications, peptides
Offered with honest framing: promising mechanisms, evolving evidence. We tell you exactly what is and is not known.
We will say no. If the evidence does not support something — however fashionable — we will tell you plainly. Longevity medicine earns trust by what it refuses to sell.
The science we practice stands on decades of published research — these are some of the bodies of evidence our clinical reasoning draws on.
A standard panel is built to detect existing disease. Ours is built to measure the trajectory toward it. Markers like ApoB, Lp(a), fasting insulin, and hs-CRP move decades before a diagnosis — and most are absent from routine checkups. More markers also means fewer blind spots across the 12 organ systems we map.
"Normal" lab ranges describe the average of a population that includes the unwell. Optimal ranges describe where the long-term risk data is lowest. Sitting at the edge of normal can still mean decades of accumulating risk — our physicians read your results against optimal, not just normal.
South Asians develop cardiovascular disease roughly a decade earlier than Western populations, and insulin resistance appears at lower body weights. Reference data built on Western cohorts under-estimates that risk. Our physicians interpret your markers in that context — it is one of the reasons physician review matters more than a printed report.
Biological-age markers respond to targeted intervention — training, sleep, metabolic and hormonal correction. Our members track their trend through quarterly retesting; protocols are adjusted based on what your data shows. No specific outcome is ever promised in advance — that is what makes this medicine rather than marketing.
No. Everything on this page is educational. Diagnosis and treatment decisions at Genoryx are made only by our physicians, after your assessment, in consultation with you.
Every protocol is physician-designed and calibrated to your biomarkers. We are conservative by design: interventions with strong evidence are core protocol; promising-but-early science is offered with honest framing; and we will tell you plainly when the evidence does not support something — even if it is fashionable.
Educational content, reviewed by Dr. R. Brahmananda Reddy, UK-trained physician. Nothing on this page is a diagnosis or treatment recommendation.
